(1H-Pyrrolo[2,3-b]pyridin-5-yl)boronic acid, 95.0%, 250mg

2-(2,3-Difluoro-6-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 5g

7-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole, 98+%, 10g

n-(Pyridin-2-yl)benzamide, 98%, 250mg

Lucitanib, 98.94%, 100mg

(2R,3R)-4-(Anthracen-9-yl)-3-(tert-butyl)-2-isopropyl-2,3-dihydrobenzo[d][1,3]oxaphosphole, 97%, 1g

3,6-DIHYDRO-2H-PYRAN-2-CARBOXYLIC ACID, 95%, 100mg

5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-pyrimidin-2-amine, 98.0%, 10g

1-Methyl-5-nitro-1,3-dihydro-2H-benzo[d]imidazol-2-one, 98+%, 1g

METHYL 6-QUINAZOLINECARBOXYLATE, 95.0%, 1g

Puntas dispensadoras Puntas PD // BIO-CERT®, 1,25 ml, 25-125 µl, 100 piezas

N2-(1H-INDAZOL-5-YL)-N6-METHYL-3-NITROPYRIDINE-2,6-DIAMINE, 95%, 10mg

Methyl 5-((tert-butoxycarbonyl)amino)-4-nitrothiophene-2-carboxylate, 97.0%, 5g